Company Search:
Advanced Search
Sponsored Links
Grindeks AS Company Snapshot
Grindeks AS operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other pharmaceutical manufacturers in Europe: Alkaloid AD Skopje of Macedonia (2018 sales of 9.78 billion Denar [US$179.43 million] of which 85% was Pharmaceuticals), Dottikon ES Holding AG of Switzerland (158.23 million Swiss Francs [US$156.97 million] of which 91% was Pharma Products), and Alliance Pharma Plc which is based in the United Kingdom (£118.21 million [US$154.32 million] of which 100% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2018, sales at Grindeks AS were 145.48 million Euro (US$164.20 million). This is an increase of 9.9% versus 2017, when the company's sales were 132.41 million Euro. This was the third consecutive year of growth at Grindeks AS.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Grindeks AS
  Stock Performance Chart for Grindeks AS
  Stock Data: Recent Stock Performance:
  Current Price (4/12/2019): 7.85
(Figures in Euro)
1 Week 0.6%   13 Weeks 0.9%  
4 Weeks 9.9%   52 Weeks 4.9%  
Grindeks AS Key Data:
  Ticker: GRD1R Country: Latvia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 145,477,001
(Year Ending Jan 2019).
Employees: 1,355
  Currency: Euro Market Cap: 75,242,250
  Fiscal Yr Ends: December Shares Outstanding: 9,585,000
  Share Type: Closely Held Shares: 6,958,711
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.